The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection

Manning EJ, Collins MT. Mycobacterium avium subsp. paratuberculosis: pathogen, pathogenesis and diagnosis. Rev Sci Tech. 2001;20:133–50. Buergelt CD, Hall C, McEntee K, Duncan JR. Pathological evaluation of paratuberculosis in naturally infected cattle. Vet Pathol. 1978;15:196–207. Whitlock RH, Buergelt C. Preclinical and clinical manifestations of paratuberculosis (including pathology). Vet Clin North Am Food Anim Pract. 1996;12:345–56. Chiodini RJ, Van Kruiningen HJ, Merkal RS. Ruminant paratuberculosis (Johne’s disease): the current status and future prospects. Cornell Vet. 1984;74:218–62. Buergelt CD, Ginn PE. The histopathologic diagnosis of subclinical Johne’s disease in North American bison (Bison bison). Vet Microbiol. 2000;77:325–31. Yadav D, Singh SV, Singh AV, Sevilla I, Juste RA, Singh PK, Sohal JS. Pathogenic ‘Bison-type’ Mycobacterium avium subspecies paratuberculosis genotype characterized riverine buffalo (Bubalus bubalis) in North India. Comp Immunol Microbiol Infect Dis. 2008;31:373–87. Abbas M, Munir M, Khalig SA, Hag MI, Tanveer Khan M, Qureshi ZU. Detection of paratuberculosis in breeding bulls at Pakistani semen production units: a continuous source of threat. IRSN Vet Sci. 2011;10:1–4. Sorge SS, Kurnick S, Streevatsan S. Detection of Myocbacterium avium subspecies paratuberculosis in the saliva of dairy cows: a pilot study. Vet Microbiol. 2013;164:383–6. Stevenson K. Genetic diversity of Mycobacterium avium subspecies paratuberculosis and the influence ofstrain type on infection and pathogenesis: a review. Vet Res. 2015;46(64):1-13. Lombard JE. Epidemiology and economics of paratuberculosis. Vet Clin North Am Food Anim Pract. 2011;27:525–35. Chiodini RJ, Chamberlin WM, Sarosiek J, McCallum RW. Crohn’s disease and the mycobacterioses: a quarter century later. Causation or simple association? Crit Rev Microbiol. 2012;38:52–93. Liverani E, Eleonora S, Carla C, Paola DM, Andrea B. Review, Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon. World J Gastroenterol. 2014;20(36):13060–70. McNees AL, Markesich D, Zayyani NR, Graham DY. Mycobacterium paratuberculosis as a cause of Crohn’s disease. Expert Rev Gastroenterol Hepatol. 2015;9(12):1523–34. Gwozdz JM, Thompson KG, Murray A, Reichel MP, Manktelow BW, West DM. Comparison of three serological tests and an interferon-gamma assay for the diagnosis of paratuberculosis in experimentally infected sheep. Aust Vet J. 2000;78:779–83. Stabel JR, Whitlock RH. An evaluation of a modified interferongamma assay for the detection of paratuberculosis in dairy herds. Vet Immunol Immunopathol. 2001;79:69–81. Leite FL, Livia BE, Bruce P, John PB, Timothy AR, Judith RS. ZAP-70, CTLA-4 and proximal T cell receptor signaling in cows infected with Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol. 2015;167:15–21. Begg DJ, de Silva K, Carter N, Plain KM, Purdie A, Whittington RJ. Does a Th1 over Th2 dominancy really exist in the early stages of Mycobacterium avium subspecies paratuberculosis infections? Immunobiology. 2011;216(7):840–6. Sommer S, Pudrith CB, Colvin CJ, Coussens PM. Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocytederived macrophages. Vet Immunol Immunopathol. 2009;128:44–52. Stokes RW, Thorson LM, Speert DP. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. J Immunol. 1998;160:5514–21. Astarie-Dequeker C, N’Diaye EN, Le Cabec V, Rittig MG, Prandi J, Maridonneau-Parini I. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect Immun. 1999;67:469–77. Fratti RA, Chua J, Deretic V. Induction of p38 mitogen-activated protein kinase reduces early endosome autoantigen 1(EEA1) recruitment to phagosomal membranes. J Biol Chem. 2003;278:46961–7. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol. 2001;167:910–8. Banaiee N, Kincaid EZ, Buchwald U, Jacobs Jr WR, Ernst JD. Potent inhibition of macrophage responses to IFN- by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol. 2006;176:3019–27. Souza CD, Evanson OA, Weiss D. Mitogen activated protein kinasep38 pathway is an important component of the anti-inflammatory response in Mycobacterium avium subsp. Paratuberculosis infected bovine monocytes. Microb Pathog. 2006;41:59–66. Weiss DJ, Souza CD, Evanson OA, Sanders M, Rutherford M. Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium. J Leukoc Biol. 2008;83:48–55. Souza C, Davis WC, Eckstein TM, Sreevatsan S, Weiss DJ. Mannosylated lipoarabinomannans from Mycobacterium avium subsp. paratuberculosis alters the inflammatory response by bovine macrophages and suppresses killing of Mycobacterium avium subsp. avium organisms. PLoS One. 2013;8(9):1–6. John PB, Judith RS, Elizabeth L, Maria Clara DC, Souza CD. Mycobacterium avium Subspecies paratuberculosis Recombinant Proteins Modulate Antimycobacterial Functions of Bovine Macrophages. PLoS ONE. 2015;10(6):1–14. Cyktor JC, Turner J. Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens. Infect Immun. 2011;79(8):2964–73. Claire EM, Frederick JS, Joseph EQ, Sarah LD, Susan RQ, Murray PJ, Luke AJ, O’Neill. IL-10 inhibits miR-155 induction by Toll-like receptors. J Biol Chem. 2010;285(27):20492–8. Nagata R, Satoko K, Yuu M, Xuebo W, Tadashi Y, Yasuyuki M. A specific induction of interleukin-10 by the Map41 recombinant PPE antigen of Mycobacterium avium subsp. Paratuberculosis. J Vet Immunol Immunopathol. 2010;135:71–8. Ejrnaes M, Christophe MF, Marianne MM, Eleanor ML, Lisa MT, Shane C, Matthias GH. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006;203:2461–72. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12:1301–9. Margarida S, Anne O’G. The regulation of IL‑10 production by immune cells. Nat Rev Immunol. 2010;10:170–81. Kaufmann SH. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis. 2002;61:54–8. Weiss DJ, Evanson OA, Souza CD. Increased expression of interleukin-10 and suppressor of cytokine signaling-3 associated with susceptibility to Johne’s disease. Am J Vet Res. 2005;66:1114–20. Verma SK, Krishnamurthy P, Girikipathi VN, Abramova T, Gumpert A, Khan M, Emily N, Johnson J, Benedict C, Koch W, Kishore R. Ang II-induced Pathological Autophagy is inhibited by IL-10 via Akt Dependent Inhibition of Beclin 1 in Mice Heart. J Cell Biol Funct. 2015;132:A14287. Feng CG, Kullberg MC, Jankovic D, Cheever AW, Caspar P, Coffman RL, Sher AA. Transgenic Mice Expressing Human Interleukin-10 in the Antigen-Presenting Cell Compartment Show Increased Susceptibility to Infection with Mycobacterium avium Associated with Decreased Macrophage Effector Function and Apoptosis. Infect Immun. 2002;70(12):6672–9. Khalifeh MS, Stabel JR. Effects of gamma interferon, interleukin-10, and transforming growth factor beta on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle. Infect Immun. 2004;72:1974–82. Reiling N, Blumenthal A, Flad HD, Ernst M, Ehlers S. Mycobacteriainduced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol. 2001;167:3339–45. Song CH, Lee JS, Lee SH, Lim K, Kim HJ, Park JK, Paik TH, Jo EK. Role of mitogen-activated protein kinase pathways in the production of tumor necrosis factor–alpha, interleukin-10, and monocyte chemotactic protein–1 by Mycobacterium tuberculosis H37Rv–infected human monocytes. J Clin Immunol. 2003;23:194–201. Souza CD, Evanson OA, Weiss DJ. Regulation by Jun N-terminal kinase/stress activated protein kinase of cytokine expression in Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes. Am J Vet Res. 2006;67:1760–5. Geijtenbeek TBH, Vliet SJ, Koppel EA, Hernandez MS, Christine MJE, Vandenbroucke-Grauls CM, Ben A, Yvette van K. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function. J Exp Med. 2003;197(1):7–17. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol. 2004;172:567–76. Murray PJ. The JAK–STAT signaling pathway: input and output integration. J Immunol. 2007;178:2623–9. Kuchipudi SV. Review Article the Complex Role of STAT3 in Viral Infections. J Immunol Res. 2015;10:1–9. Leary SO, O’Sullivan MP, Joseph K. IL-10 Blocks Phagosome Maturation in Mycobacterium tuberculosis–Infected Human Macrophages. Am J Respir Cell Mol Biol. 2011;45:172–80. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol. 1997;158(1):315–21. Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, Malefyt RW, Vesosky B, Turner J. Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice. J Immunol. 2008;181(8):5545–50. Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res. 1999;19:563–73. Buza JJ, Hikono H, Mori Y, Nagata R, Hirayama S, Aodon-geril, Bari AM, Shu Y, Tsuji NM, Momotani E. Neutralization of interleukin-10 significantly enhances gamma interferon expression in peripheral blood by stimulation with Johnin purified protein derivative and by infection with Mycobacterium avium subsp. paratuberculosis in experimentally infected cattle with paratuberculosis. Infect Immun. 2004;72:2425–8. Lybeck KR, Storset AK, Olsen I. Neutralisation of interleukin-10 from CD14+ monocytes enhances gamma interferon production in peripheral blood mononuclear cells from Mycobacterium avium subsp. paratuberculosis infected goats. Clin Vaccine Immunol. 2009;16:1003–11. Khalifeh MS, Stabel JR. Upregulation of transforming growth factor-beta and interleukin-10 in cows with clinical Johne’s disease. Vet Immunol Immunopathol. 2004;99:39–46. Berger ST, Griffin FT. A comparison of ovine monocyte-derived macrophage functions following infection with Mycobacterium avium ssp. avium and Mycobacterium avium ssp. paratuberculosis. Immunol Cell Biol. 2006;84:349–56. Lei L, Hostetter JM. Limited phenotypic and functional maturation of bovine monocyte-derived dendritic cells following Mycobacterium avium subspecies paratuberculosis infection in vitro. Vet Immunol Immunopathol. 2007;120:177–86. Coussens PM, Verman N, Coussens MA, Elftman MD, McNulty AM. Cytokine gene expression in peripheral blood mononuclear cells and tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis: evidence for an inherent proinflammatory gene expression pattern. Infect Immun. 2004;72:1409–22. Janagama HK, Kwang IJ, Vivek K, Paul C, Srinand S. Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains.j. BMC Microbiol. 2006;6(10):1–12. Smeed JA, Watkins CA, Rhind SM, Hopkins J. Differential cytokine gene expression profiles in the three pathological forms of sheep paratuberculosis. BMC Vet Res. 2007;3(18):1–11. Narnaware SD, Periasamy S, Tripathi BN. Studies on pathology, cytokine gene expression and molecular typing of Mycobacterium avium subsp. paratuberculosis of naturally occurring Johne’s disease in bullocks. Res Vet Sci. 2016;106:74–80. Nagata R, Muneta Y, Yoshihara K, Yokomizo Y, Mori Y. Expression cloning of gamma interferon-inducing antigens of Mycobacterium avium subsp. paratuberculosis. Infect Immun. 2015;73:3778–82. Bermudez L, Champs J. Infection with Mycobacterium avium Induces Production of Interleukin-10(IL-10), and Administration of Anti-IL-10 Antibody Is Associated with Enhanced Resistance to Infection in Mice. Infect Immun. 1993;61(7):3093–7. Roque S, Nobrega C, Appelberg R, Neves MC. IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy. J Immunol. 2007;178:8028–35. Jacobs M, Brown N, Allie N, Gulert R, Ryffel B. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology. 2000;100:494–501. Murray PJ and Young RA. Increased antimicrobial immunity in interleukin-10-deffecient mice. Infect Immun. 1999;67:3087-95. Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev. 2007;219:167–86. Weiss DJ, Evanson O, Souza CD. Critical role of interleukin-10 in the response of bovine macrophages to infection by Mycobacterium avium sub paratuberculosis. Am J Vet Res. 2005;66:21–726. Raja A. Immunology of tuberculosis. Indian J Med Res. 2004;120:213–32. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994;84(12):4008–27. Grohmann U, Belladonna ML, Vacca C, Bianchi R, Fallarino F, Orabona C, Fioretti MC, Puccetti P. Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J Immunol. 2001;167(1):221–7. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996;183(1):147–57. D’Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibit human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993;178(3):1041–8. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol. 1998;160(12):5936–44. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM, Cooper AM. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice. J Immunol. 2002;169:6343–51. Clark IA. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007;18:335–43. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Sieqel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098–104. Joan KR, Takeda K, Akira S, Schreiber RD. Interleukin-10 Receptor Signaling through the JAK-STAT Pathway requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem. 1999;274(23):16513–21. Khalifeh MS, Al-Majali AM, Stabel JR. Role of nitric oxide production in dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol. 2009;131:97–104. Pitt JM, Stavropoulos E, Redford PS, Beebe AM, Bancroft GJ, Young DB, O’Garra AA. Blockade of IL-10 Signaling during Bacillus Calmette-Guerin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-g and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection. J Immunol. 2012;189:4079–87. Sullivan BM, Ousman J, Vanja L, Kristine V, Roderick B, Laurie HG and Igor K. Increased Susceptibility of Mice Lacking T-bet to Infection with Mycobacterium tuberculosis Correlates with Increased IL-10 and Decreased IFN-γ Production. J Immunol. 2005;175:4593–602. Obermair CP, Albrecht-Schgoer K, Peer S, Nairz M, Siegmund K, Klepsch V, Haschka D, Thuille N, Hermann-Kleiter N, Gruber T, Weiss G, Baier G. Role of PKCtheta in macrophage-mediated immune response to Salmonella typhimurium infection in mice. Cell Commun Signal. 2016;14(14):2–8. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol. 2002;168:6404–11. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081–95. Chang EY, Guo B, Doyle SE, Cheng G. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol. 2007;178:6705–9. Stabel JR, Kimura K, Robbe-Austerman S. Augmentation of secreted and intracellular gamma interferon following johnin purified protein derivative sensitization of cows naturally infected with Mycobacterium avium subsp. paratuberculosis. J Vet Diagn Investig. 2007;19:43–51. Stabel JR. Host responses to Mycobacterium avium subsp. paratuberculosis: a complex arsenal. Anim Health Res Rev. 2006;7:61–70. Lin PG, Flynn JL. Understanding latent tuberculosis: a moving target. J Immunol. 2010;185(1):15–22. Stabel JR, Robbe-Austerman S. Early immune markers associated with Mycobacterium avium subsp. paratuberculosis infection in a neonatal calf model. Clin Vaccine Immunol. 2011;18:393–405. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM. IL-23 and IL- 17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8(4):369–77. de Silva K, Begg D, Carter N, Taylor D, Di Fiore L, Whittington R. The early lymphocyte proliferation response in sheep exposed to Mycobacterium avium subsp. paratuberculosis compared to infection status. Immunobiology. 2010;215(1):12–25. O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MPR. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527. de Silva K, Begg D, Whittington R. The interleukin 10 response in ovine Johne’s disease. Vet Immunol Immunopathol. 2011;139(1):10–6. Tanaka S, Sato M, Onitsuka T, Kamata H, Yokomizo Y. Inflammatory cytokine gene expression in different types of granulomatous lesions during asymptomatic stages of bovine paratuberculosis. Vet Pathol. 2005;42(5):579–88. Gesham M, Eda S, Stabel J. Predicting the Role of IL-10 in the Regulation of the Adaptive Immune Responses in Mycobacterium avium Subsp. Paratuberculosis Infections Using Mathematical Models. PLoS ONE. 2015;10(11):1–25. Almeida AS, Lago PM, Boechat N, Huard RC, Lazzarini LC, Santos AR, Nociari M, Zhu H, Perez-Sweeney BM, Bang H, et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol. 2009;183:718–31. Redford PS, Murray PJ, O’Garra A. The role of IL-10 in immune regulationduring M. tuberculosis infection. Mucosal Immunol. 2011;4:261–70. Singh AK, Thirumalapura NR. Early Induction of Interleukin-10 Limits Antigen-Specific CD4 T cell Expansion, Function, and Secondary Recall Responses during Persistent Phagosomal Infection. Infect Immun. 2014;82(10):4092–103. Xavier MN, Winter MG, Spees AM, Nguyen K, Atluri VL, Silva TMA, Baumler AJ, Muller W, Santos RL, Tsolis RM. CD4+ T Cell-derived IL-10 Promotes Brucella abortus Persistence via Modulation of Macrophage Function. PLoS Pathog. 2013;9(6):1–17. Stabel JR. Transitions in immune responses to Mycobacterium paratuberculosis. Vet Microbiol. 2000;77:465–73. Luzio JP, Pryor PR, Bright NA. Review, Lysosome fusion and Function. Nat Rev Mol Cell Biol. 2007;8:622–32. Xu S, Cooper A, Sturgill-Koszycki S, Van Heyningen T, Chatterjee D, Orme I, Allen P, Russell D. Intracellular traficking in Mycobacterium tuberculosis and Mycobacterium aviuminfected macrophages. J Immunol. 1994;153:2568–78. Ramachandra L, Noss E, Boom W, Harding C. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J Exp Med. 2001;194:1421–32. Kuehnel MP, Goethe R, Habermann A, Mueller E, Rohde M, Griffiths G, Valentin-Weigand P. Characterization of the intracellular survival of Mycobacterium avium ssp. paratuberculosis: phagosomal pH and fusogenicity in J774 macrophages compared with other mycobacteria. Cell Microbiol. 2001;3:551–66. Schaible U, Sturgill-Koszychi S, Schlesinger P, Russell D. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol. 1998;160:1290–6. Nelson N. The vacuolar Hþ-APTase one of the most fundamental ion pumps in nature. J Exp Biol. 1992;172:19–27. Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol. 2003;170:430–7. Pena AS, Karimi O, Crusius JB. A new avenue to investigate: the autophagic process. From Crohn’s disease to Chlamydia. Drugs Today (Barc). 2009;45:113–7. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signaling pathways. Nat Rev. 2004;2:189–202. Tessema MZ, Koets AP, Rutten VP, Gruys E. How does Mycobacterium avium subsp. paratuberculosis resist intracellular degradation? Vet Q. 2001;23:153–62. Souza CD, Weiss DJ, Evanson OA. Role of the MAPK-ERK pathway in regulating cytokine expression by Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes. Am J Vet Res. 2007;68(6):625–30. Patel NR, Swan K, Li X, Tachado SD, Koziel H. Impaired M. tuberculosis–mediated apoptosis in alveolar macrophages from HIV1 persons: potential role of IL-10 and BCL-3. J Leukoc Biol. 2009;86:53–60. Yin Y, Liu W, Ji G, Dai Y. The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis. Eur J Cell Biol. 2013;92:150–9. Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller FHH, Tonstad S, Hall C, Froland SS, Biessen EA, Damås JK, Aukrust P. Interleukin-10 enhances the oxidized LDL induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res. 2005;46:211–9. Madonna S, Scarponi C, Pallotta S, Cavani A, Albanesi C. Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. Cell Death Dis. 2012;10(3):1–11. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, Ivashkiv LB. IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity. 2006;24:563–74. Neta MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. Toll like receptor-2 supress immunity against candida alibicans through induction of Il-10 and regulatory T cells. J Immunol. 2004;172:3712–8. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372(6508):739-46. Hommes DW, Peppelenbosch MP, van Deventer SJH. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut. 2002;52:144–51. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911–2. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol. 2006;6:532–40. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, Pereira JP, Bates EE, Akira S, Vieira P, Liu YJ, Trinchieri G, O’Garra A. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIFdependent TLR signals, and TLR-independent signals. J Immunol. 2006;177:7551–8. Doyle SL, O’Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol. 2006;72(9):1102–13. Bright bill H, Plevy S, Modlin R, Smale S. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol. 2000;164:1940–51. Liu YW, Tseng HP, Chen LC, Chen BK, Chang WC. Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages. J Immunol. 2003;171(2):821–8. Cao S, Liu J, Song L, Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol. 2005;174(6):3484–92. Liu YW, Chen CC, Tseng HP, Chang WC. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages. Cell Signal. 2006;18(9):1492–500. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JS. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol. 2008;9(9):1028–36. Iyer SS, Cheng G. Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease. Crit Rev Immunol. 2012;32(1):23–63. Lawrence T. The Nuclear Factor NF-kB Pathway in Inflammation. Cold Spring Harb Perspect Biol. 2009;10(1):1–10. Tomczak MF, Erdman SE, Davidson A, Wang YY, Nambiar PR, Rogers AB, Rickman B, Luchetti D, Fox JG, Horwitz BH. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-κB. J Immunol. 2006;177:7332–9. Cao S, Zhang X, Edwards JP, David MM. NF-kB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages. J Biol Chem. 2006;281(36):26041–50. Duncan SA, Zhong Z, Wen Z, Darnell Jr JE. STAT signaling is active during early mammalian development. Dev Dyn. 1997;208(2):190–8. Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv. 2011;11(1):18–26. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998;67:227–64. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798–809. Staples KJ, Smallie T, Williams LM, Foey A, Burke B, Foxwell BMJ, Heitbrock LZ. IL-10 Induces IL-10 in Primary Human Monocyte-Derived Macrophages via the Transcription Factor Stat3. J Immunol. 2007;178:4779–85. Paul G, Khare V, Gasche C. Inflamed gut mucosa: downstream of interleukin-10. Eur J Clin Invest. 2012;42:95–109. Brenner S, Prösch S, Schenke-Layland K, Riese U, Gausmann U, Platzer C. CAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem. 2003;278:5597–604. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, et al. Loss ofSOCS3 in T helper cells resulted in reduced immune responses and hyperpro-duction of interleukin 10 and transforming growth factor-beta 1. J Exp Med. 2006;203:1021–31. Hoentjen F, Sartor RB, Ozaki M, Jobin C. STAT3 regulates NF-kappaB recruit-ment to the IL-12p40 promoter in dendritic cells. Blood. 2005;105:689–96. Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X. Modulation of T cell cytokine production by miR-144 with elevated expression in patients with pulmonary tuberculosis. Mol Immunol. 2011;48:1084–90. Turner ML, Schnorfeil FM, Brocker T. MicroRNAs regulate dendritic cell differentiation and function. J Immunol. 2011;187(8):3911–7. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10:111–22. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889–96. Ma S, Liu M, Xu Z, Li Y, Guo H, Ge Y, Liu Y, Zheng D, Shi J. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression. Oncotarget. 2016;7(12):13502–19. Feng M, Xingguang L, Dong L, Pin W, Nan L, Liwei L, Xuetao C. MicroRNA-466 l Upregulates IL-10 Expression in TLR-Triggered Macrophages by Antagonizing RNA-Binding Protein Tristetraprolin-Mediated IL-10 mRNA Degradation. J Immunol. 2010;184:6053–9. Rossatoa M, Curtaleb G, Tamassiaa N, Castelluccia M, Morib L, Gasperinia S, Mariottia B, Lucab MD, Mirolob M, Cassatellaa MA, Locatib M, Bazzonia F. IL-10–induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. PNAS. 2012;109(45):E3101–3110. Cardwell LN, WeaverB K. IL-10 Inhibits LPS-Induced Expression of miR-147 in Murine Macrophages. Adv Biol Chem. 2014;4:261–73. Liu Y, Chen Q, Song Y, Lai L, Wang J, Yu H, Cao X, Wang Q. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett. 2011;585:1963–8. Xie N, Cui H, Banerjee S, Tan Z, Salomao R, Fu M, Abraham E, Thannickal VJ, Liu G. miR-27a Regulates Inflammatory Response of Macrophages by Targeting IL-10. J Immunol. 2014;193:327–34. Freilich RW, Woodbury ME, Ikezu T. Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia. PLoS ONE. 2013;8(11):79416. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol. 2009;86:411–21. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Immunology. 2005;11:750–61. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166–73. Ouimet M, Hasini NE, Mahesh GU, Frederick JS, Bhama R, Susan BH, Kaitlyn R, Coen VS, Morgan DF, Katharine C, Katey JR, Gregory RS, Phillip DZ, Edward AF, Png L, Kathryn JM. MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest. 2015;125(12):4334–48. Su R, Dong L, Zou D, Zhao H, Ren Y, Li F, Yi P, Li L, Zhu Y, Ma Y, Wang J, Wang F, Yu J. microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia. Oncogene. 2016;35:6001–14. Li W, Huang H, Su J, Ji X, Zhang X, Zhang Z, Wang H. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3. Mol Neurobiol. 2016 doi: 10.1007/s12035-016-9852-z. Hong L, Ya-Wei L, Hai W, Qiang Z, Jun-Jie L, Huang A, Song-Tao Q, Yun-Tao LJ. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway. J Neurooncol. 2016;128(1):35–45. Wang X, Qiu W, Zhang G, Xu S, Gao Q, Yang Z. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through theSTAT3/BCl-2/survivin pathway. Int J Clin Exp Pathol. 2015;8(5):5017–25. Kalechman Y, Gafter U, Weinstein T, Chagnac A, Freidkin I, Tobar A. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J Biol Chem. 2004;279(24):724–32. Pengal RA, Ganesan LP, Wei G, Fang H, Ostrowski MC, Tridandapani S. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol Immunol. 2006;43:1557–64. Sinuani I, Joshua W, Ilia B, Micha JR, Judit S, Leonid F, Michael A, Zhan A, Benjamin S. The cyclin kinase inhibitor p57kip2 regulates TGF-β-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. Nephrol Dial Transplant. 2009;24:2328–38. Myers RR, Sekiguchi Y, Kikuchi S, Scott B, Medicherla S, Protter A, Campana WM. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol. 2003;184:606–14. Xiang D, Yuan Y, Li CXL, Chandra B, Hua C. Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes. Biochem Biophys Res Commun. 2015;464(1):221–8. Shou Y, Rui L, Dongkyoo P, Maohua X, Gabriel LS, Ya C, Zhi-Qiang X, Xingming D. Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer. Mol Cancer Ther. 2014;13(3):606–16. Farrell D, Shaughnessy RG, Britton L, David E, Mac H, Bryan M, Stephen VG. The Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection. PLoS ONE. 2015;10(7):1–22. Shaughnessy RG, Farrell D, Riepema K, Bakker D, Stephen V, Gordon SV. Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire. PLoS ONE. 2015;10(12):1–2.